» Articles » PMID: 12163368

A Role for Tumor Necrosis Factor-alpha in Remodeling the Splenic Marginal Zone During Leishmania Donovani Infection

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2002 Aug 7
PMID 12163368
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The development of secondary lymphoid organs is a highly regulated process, mediated by tumor necrosis factor (TNF) family cytokines. In contrast, the mechanisms controlling changes in lymphoid architecture that occur during infectious disease are poorly understood. Here we demonstrate that during infection with Leishmania donovani, the marginal zone of mice undergoes extensive remodeling, similar in extent to developmental abnormalities in mice lacking some TNF family cytokines. This process is selective, comprising a dramatic and rapid loss of marginal zone macrophages (MZMs). As a functional consequence, lymphocyte traffic into the white pulp is impaired during chronic leishmaniasis. Significantly, MZMs were preserved in L. donovani-infected B6.TNF-alpha(-/-) mice or mice that received anti-TNF-alpha antibodies, whereas studies in CD8(+) T-cell-deficient mice and in mice lacking functional CD95L, excluded a direct role for either cytotoxic T lymphocyte activity or CD95-mediated apoptosis in this process. Loss of MZMs was independent of parasite burden, yet could be partially prevented by chemotherapy, which in turn reduced endogenous TNF-alpha levels. This is the first report of an infectious agent causing selective and long-lasting changes to the marginal zone via TNF-alpha-mediated mechanisms, and illustrates that those cytokines involved in establishing lymphoid architecture during development, may also play a role in infection-induced lymphoid tissue remodeling.

Citing Articles

A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.

Edwards C, Engel J, De Labastida Rivera F, Ng S, Corvino D, Montes de Oca M JCI Insight. 2023; 8(24).

PMID: 37917177 PMC: 10807716. DOI: 10.1172/jci.insight.169362.


Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease.

Kawashima K, Onizawa M, Fujiwara T, Gunji N, Imamura H, Katakura K Medicine (Baltimore). 2022; 101(1):e28515.

PMID: 35029912 PMC: 8735780. DOI: 10.1097/MD.0000000000028515.


Liver- and Spleen-Specific Immune Responses in Experimental Infection in BALB/c Mice.

Sukhumavasi W, Kaewamatawong T, Somboonpoonpol N, Jiratanh M, Wattanamethanont J, Kaewthamasorn M Front Vet Sci. 2022; 8:794024.

PMID: 34977224 PMC: 8718515. DOI: 10.3389/fvets.2021.794024.


Splenic Transcriptional Responses in Severe Visceral Leishmaniasis: Impaired Leukocyte Chemotaxis and Cell Cycle Arrest.

Vilas Boas de Melo C, Torres F, Hermida M, Fontes J, Mesquita B, Brito R Front Immunol. 2021; 12:716314.

PMID: 34804009 PMC: 8602831. DOI: 10.3389/fimmu.2021.716314.


Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition.

Bulte D, Van Bockstal L, Dirkx L, van den Kerkhof M, De Trez C, Timmermans J PLoS Negl Trop Dis. 2021; 15(7):e0009622.

PMID: 34292975 PMC: 8330912. DOI: 10.1371/journal.pntd.0009622.


References
1.
Murray H, Oca M, Granger A, Schreiber R . Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. J Clin Invest. 1989; 83(4):1253-7. PMC: 303815. DOI: 10.1172/JCI114009. View

2.
Engwerda C, Smelt S, Kaye P . An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp Parasitol. 1996; 84(2):195-202. DOI: 10.1006/expr.1996.0105. View

3.
WEISS L . Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am J Trop Med Hyg. 1989; 41(2):144-60. DOI: 10.4269/ajtmh.1989.41.144. View

4.
Blackwell J, Roach T, Kiderlen A, Kaye P . Role of Lsh in regulating macrophage priming/activation. Res Immunol. 1989; 140(8):798-805. DOI: 10.1016/0923-2494(89)90036-9. View

5.
Barral-Netto M, Badaro R, Barral A, Almeida R, Santos S, Badaro F . Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis. 1991; 163(4):853-7. DOI: 10.1093/infdis/163.4.853. View